Related Experiment Video
Updated: Aug 8, 2026
11:11
Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
Published on: January 24, 2020
[Clinical application of anticancer cytokines]
1Department of Internal Medicine (Section 4), Sapporo Medical College.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 1, 1992
Summary
Anticancer cytokines show promise but have limited effectiveness alone. Combining them with chemotherapy, particularly interferon, may improve outcomes for certain cancers, but optimal dosing strategies require further research.
Area of Science:
- Immunology
- Oncology
- Pharmacology
Context:
- Review of clinical applications of anticancer cytokines including interferons, interleukin-1, interleukin-2, and tumor necrosis factor.
- Cytokines have demonstrated utility against drug-refractory tumors but exhibit limited spectrum and efficiency.
- Clinical trial results have been generally disappointing due to these limitations.
Purpose:
- To review the clinical applications of anticancer cytokines.
- To highlight the potential of combination therapies involving cytokines and conventional anticancer drugs.
- To identify areas for future research in optimizing cytokine-based treatments.
Summary:
- Anticancer cytokines (interferons, IL-1, IL-2, TNF) are reviewed for clinical use.
- While effective against some refractory tumors, their standalone efficacy is limited.
- Recent studies show combined efficacy of interferon with chemotherapy in multiple myeloma and colorectal carcinoma.
Impact:
- Suggests combination therapy as a promising strategy for specific malignancies.
- Emphasizes the need for more basic and clinical data on optimal dose, schedule, and sequence for combination treatments.
- Guides future research towards developing more effective cytokine-based cancer therapies.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...